CALU 抗体 (AA 1-315)
Quick Overview for CALU 抗体 (AA 1-315) (ABIN2591548)
抗原
See all CALU 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-315
- 
                                            特异性
- Human CALU / Calumenin
- 
                                            纯化方法
- Affinity purified
- 
                                            免疫原
- 
                        Full length human CALU, aa1-315 (NP_001210).
 Type of Immunogen: Recombinant protein
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Approved: IF (10 μg/mL), WB
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, pH 7.2.
- 
                                            注意事项
- Aliquot to avoid repeated freezing and thawing.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
 
- 
                                            
- 
    - CALU (Calumenin (CALU))
- 
                                            别名
- CALU / Calumenin
- 
                                            背景
- 
                        Name/Gene ID: CALU
 Synonyms: CALU, Crocalbin, Multiple EF-hand protein, Calumenin, Crocalbin-like protein, IEF SSP 9302
- 
                                            基因ID
- 813
- 
                                            NCBI登录号
- NP_001210
 抗原
- 
                    
 
                                     
                                     
                                    